Inhibikase Therapeutics, Inc. · NASDAQ:IKT

Nantahala Capital Management, LLC reported a 7.54% stake in Inhibikase Therapeutics, Inc. (Schedule 13G)

Event Dec 31, 2024 · Filed Feb 14, 2025

Nantahala Capital Management, LLC reported a 7.54% stake in Inhibikase Therapeutics, Inc., 5,298,624 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G).

Stake
7.54%
Shares
5,298,624
Intent
Passive
What changed
Crossed above 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Nantahala Capital Management, LLC7.54%5,298,624
Wilmot B. Harkey7.54%5,298,624
Daniel Mack7.54%5,298,624

Source

View original at SEC

Related